Skip to main content
Log in

Einsatz von Belatacept nach Nierentransplantation ohne Erhaltungstherapie mit Steroiden oder Calcineurininhibitoren

Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ford M, Koehn B, Wagener M et al (2007) Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med 204:299–309

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Gao W, Lu Y, El Essawy B et al (2007) Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 7:1722–1732

    Article  CAS  PubMed  Google Scholar 

  3. Rostaing L, Vincenti F, Grinyó J et al (2013) Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant 13:2875–2883

    Article  CAS  PubMed  Google Scholar 

  4. Vincenti F, Larsen C, Durrbach A et al (2005) Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353:770–781

    Article  CAS  PubMed  Google Scholar 

  5. Xu H, Perez S, Cheeseman J et al (2014) The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. Am J Transplant 14:319–332

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

J. Beimler weist auf folgende Beziehungen hin: Vortragshonorar von Bristol-Myers Squibb.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Beimler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beimler, J. Einsatz von Belatacept nach Nierentransplantation ohne Erhaltungstherapie mit Steroiden oder Calcineurininhibitoren. Nephrologe 10, 49–50 (2015). https://doi.org/10.1007/s11560-014-0915-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-014-0915-8

Navigation